|
Sorted by: Date | Top Results
|
|
Author |
|
Date |
| |
| |
| 1. |
Re: Here&&39;s why conf. call is BAD NEWS tmrw 
Don't read too much into the timing of the cc.
Business & Finance > Investments > Stocks (A to Z) > Stocks P >
Poniard Pharmaceuticals Inc. (PARD)
|
|
kenhokb |
|
16-Nov-09 02:48 am |
| |
| 2. |
2ND phase 3 still has potential.
The 2nd phase 3 trial still has a good chance of being
positive in view of the trial design and droxidopa's
long history of use in Japan.
Business & Finance > Investments > Stocks (A to Z) > Stocks C >
Chelsea Therapeutics International Ltd.
|
|
kenhokb |
|
3-Nov-09 09:49 am |
| |
| 3. |
ABthrax PDUFA 20 Nov..Better to take profits now.
If not for the PDUFA for ABthrax on 20 Nov, I would
have held on to HGSI. However, I would consider buying
back in after the PDUFA date, because IMHO, a complete
response letter will be...
Business & Finance > Investments > Stocks (A to Z) > Stocks H >
Human Genome Sciences (HGSI)
|
|
kenhokb |
|
2-Nov-09 11:20 am |
| |
| 4. |
Anyone listening to the cc?
Any mention of the cause of death for the 3 patients
on Benlysta?
Business & Finance > Investments > Stocks (A to Z) > Stocks H >
Human Genome Sciences (HGSI)
|
|
kenhokb |
|
2-Nov-09 07:56 am |
| |
| 5. |
Re: Conference Call
Is the conference call available at HGSI website now?
I have registered to listen to the cc, but the site
brings me to a test page only???
Business & Finance > Investments > Stocks (A to Z) > Stocks H >
Human Genome Sciences (HGSI)
|
|
kenhokb |
|
2-Nov-09 07:41 am |
| |
| 6. |
3 deaths and 5 malignancies...?
"Malignancies were reported by 2, 3, and 1 subjects
in the belimumab 10 mg/kg, belimumab 1 mg/kg and placebo
groups, respectively. There were three deaths...
Business & Finance > Investments > Stocks (A to Z) > Stocks H >
Human Genome Sciences (HGSI)
|
|
kenhokb |
|
2-Nov-09 05:15 am |
| |
| 7. |
Bashers will be out in full force these 2 days..
As you can see, there are many bashers today. Don't
fall prey to them.
Business & Finance > Investments > Stocks (A to Z) > Stocks H >
Human Genome Sciences (HGSI)
|
|
kenhokb |
|
29-Oct-09 08:45 am |
| |
| 8. |
Re: Don&&39;t sell your shares cheap..
2nd Nov is the day HGSI will release the results of
the second phase 3 trial (BLISS-76) of Benlysta for
SLE. The first phase 3 trial was positive.
Business & Finance > Investments > Stocks (A to Z) > Stocks H >
Human Genome Sciences (HGSI)
|
|
kenhokb |
|
28-Oct-09 09:00 am |
| |
| 9. |
Don&&39;t sell your shares cheap..
Now we're on the home run stretch to the Benlysta
results. Remember there will be a lot of bashers trying
to scare you into selling cheap. Don't fall for
it. Now that the ABthrax issue has...
Business & Finance > Investments > Stocks (A to Z) > Stocks H >
Human Genome Sciences (HGSI)
|
|
kenhokb |
|
28-Oct-09 08:03 am |
| |
| 10. |
$30 on positive Benlysta news.
IMHO HGSI will hit $30 or more if BLISS-76 trial is
positive, simply because there has not been any SLE
drug approved for 50 years. The Abthrax FDA panel
review is just a side issue...
Business & Finance > Investments > Stocks (A to Z) > Stocks H >
Human Genome Sciences (HGSI)
|
|
kenhokb |
|
27-Oct-09 11:43 am |
| |
| 11. |
Why is this tanking?
Only serious answers please.
Business & Finance > Investments > Stocks (A to Z) > Stocks G >
Generex Biotechnology (GNBT)
|
|
kenhokb |
|
27-Oct-09 11:09 am |
| |
| 12. |
Now VVUS just has to wait for partnership with big pharmas...
Now that all the data is out for all 3 companies with
VVUS coming out tops, VVUS has a good chance of partnership
with big pharmas.
Business & Finance > Investments > Stocks (A to Z) > Stocks V >
VIVUS, Inc. (VVUS)
|
|
kenhokb |
|
26-Oct-09 10:01 am |
| |
| 13. |
Re: Why did ARNA not elaborate on the improvement in co-morbidities?
Like I said, even if the p value is <0.0001, but
the improvement in HbA1C was lets say 0.1(hardly any
improvement at all), then the p value means nothing.
Looking at the way they...
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
Arena Pharmaceuticals (ARNA)
|
|
kenhokb |
|
26-Oct-09 07:00 am |
| |
| 14. |
Why did ARNA not elaborate on the improvement in co-morbidities?
Speaking from a medical point of view... All they said
was "lorcaserin patients also achieved highly
significant improvements in HbA1C over one year of
treatment (p<0...
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
Arena Pharmaceuticals (ARNA)
|
|
kenhokb |
|
25-Oct-09 09:48 pm |
| |
| 15. |
Re: Why Vivus will NOT fail.
You cannot take J&J's experience with topomax as
the be all and end all for Vivus. Firstly the doseage
of topomax used in Qnexa was probably different. Have
you not heard the common saying "the dose...
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
Arena Pharmaceuticals (ARNA)
|
|
kenhokb |
|
23-Oct-09 10:52 am |
| |
| 16. |
This weekend should be interesting for Vivus at the Obesity conference.
http://ir.vivus.com/releasedetail.cfm?ReleaseID=41
3537
Business & Finance > Investments > Stocks (A to Z) > Stocks V >
VIVUS, Inc. (VVUS)
|
|
kenhokb |
|
23-Oct-09 09:55 am |
| |
| 17. |
Re: Secondary pricing tonight
Looks like some pre-market interest in Eurand toda
y.
Business & Finance > Investments > Stocks (A to Z) > Stocks E >
Eurand N.V. (EURX)
|
|
kenhokb |
|
22-Oct-09 08:41 am |
| |
| 18. |
Re: Anybody holding this?
Wait for 4Q09 launch of Zenpep. Should head north after
launch.
Business & Finance > Investments > Stocks (A to Z) > Stocks E >
Eurand N.V. (EURX)
|
|
kenhokb |
|
20-Oct-09 12:06 pm |
| |
| 19. |
Time to exit when a stock is being played like a ping pong match..
you can be sure Adam has more ammunition up his sleeves,
to be released each time CVM releases good news.
Business & Finance > Investments > Stocks (A to Z) > Stocks C >
Cel-Sci Corporation (CVM)
|
|
kenhokb |
|
19-Oct-09 12:58 pm |
| |
| 20. |
Re: Get in before full data presentation of Bliss-52 at ACR on 20 Oct.
In fact, HGSI is presenting at ACR on 20th and 21st
Oct. ACR/ARHP 2009 Annual Scientific Meeting Belimumab,
a BLyS-Specific Inhibitor, Reduced Disease Activity,
Flares and Prednisone Use...
Business & Finance > Investments > Stocks (A to Z) > Stocks H >
Human Genome Sciences (HGSI)
|
|
kenhokb |
|
16-Oct-09 01:34 pm |
| |
